Further, PD-L1 expression in breast carcinomas, associated with increased density of stroma tumor-infiltrating lymphocytes (sTILs), shows a plausible predictive value for response to chemotherapy, especially in the context of neoadjuvance16–18. Here, CD274 is linked to breast carcinoma.